SPOTLIGHT: Shire gets Vyvanse nod for adult use


Shire got its longed-for blessing from the FDA to sell Vyvanse, an ADHD treatment, for use in adults. Some one-third of Vyvanse scrips already go to grownups, off-label, but the FDA OK will let Shire promote the med--and promote it, it will. Release | Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.